The M-OVIN study: does switching treatment to FSH and/or IUI lead to higher pregnancy rates in a subset of women with world health organization type II anovulation not conceiving after six ovulatory cycles with clomiphene citrate - a randomised controlled trial

Marleen J. Nahuis, Nienke S. Weiss, Fulco van der Veen, Ben Willem J. Mol, Peter G. Hompes, Jur Oosterhuis, Nils B. Lambalk, Jesper M. J. Smeenk, Carolien A. M. Koks, Ron J. T. van Golde, Joop S. E. Laven, Ben J. Cohlen, Kathrin Fleischer, Angelique J. Goverde, Marie H. Gerards, Nicole F. Klijn, Lizka C. M. Nekrui, Ilse A. J. van Rooij, Diederik A. Hoozemans, Madelon van Wely

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Article numberUNSP 42
JournalBMC Women's Health
Volume13
Issue number1
DOIs
Publication statusPublished - 25 Oct 2013

Cite this

Nahuis, M. J., Weiss, N. S., van der Veen, F., Mol, B. W. J., Hompes, P. G., Oosterhuis, J., Lambalk, N. B., Smeenk, J. M. J., Koks, C. A. M., van Golde, R. J. T., Laven, J. S. E., Cohlen, B. J., Fleischer, K., Goverde, A. J., Gerards, M. H., Klijn, N. F., Nekrui, L. C. M., van Rooij, I. A. J., Hoozemans, D. A., & van Wely, M. (2013). The M-OVIN study: does switching treatment to FSH and/or IUI lead to higher pregnancy rates in a subset of women with world health organization type II anovulation not conceiving after six ovulatory cycles with clomiphene citrate - a randomised controlled trial. BMC Women's Health, 13(1), [UNSP 42 ]. https://doi.org/10.1186/1472-6874-13-42